Stocks Overview

LAST PRICE
14.2400
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
13.5000/ 3
Ask / Lots
14.7800/ 5
Open / Previous Close
13.7400 / 14.2400
Day Range
Low 13.5700
High 14.5800
52 Week Range
Low 12.9000
High 75.6800
Volume
1,736,223
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 13.61
Time	Volume	CVAC
09:32 ET	6067	13.69
09:34 ET	6963	13.84
09:36 ET	4328	13.64
09:38 ET	33351	13.68
09:39 ET	24477	13.695
09:41 ET	5050	13.685
09:43 ET	1902	13.66
09:45 ET	26512	13.72
09:48 ET	14490	13.73
09:50 ET	7096	13.82
09:52 ET	9910	13.93
09:54 ET	7400	14
09:56 ET	18515	13.95
09:57 ET	1000	13.98
09:59 ET	1400	14
10:01 ET	19982	13.99
10:03 ET	7923	13.8773
10:06 ET	1542	13.9
10:08 ET	7474	13.915
10:10 ET	11748	13.88
10:12 ET	21888	13.84
10:14 ET	600	13.84
10:15 ET	10411	13.8
10:17 ET	2086	13.84
10:19 ET	20427	13.885
10:21 ET	10600	14.015
10:24 ET	12354	13.9782
10:26 ET	900	13.91
10:28 ET	10174	13.87
10:30 ET	1115	13.87
10:32 ET	100	13.86
10:33 ET	300	13.84
10:35 ET	226674	14.03
10:37 ET	17700	14
10:39 ET	3778	14.11
10:42 ET	89035	14.2325
10:44 ET	22035	14.1939
10:46 ET	400	14.165
10:48 ET	15600	14.2188
10:50 ET	2033	14.19
10:51 ET	100	14.2
10:53 ET	2497	14.2
10:55 ET	5037	14.326
10:57 ET	7818	14.3971
11:00 ET	8382	14.37
11:02 ET	23449	14.38
11:04 ET	15327	14.39
11:06 ET	8960	14.32
11:08 ET	2690	14.3597
11:09 ET	7648	14.46
11:11 ET	7398	14.44
11:13 ET	12940	14.445
11:15 ET	927	14.51
11:18 ET	18225	14.445
11:20 ET	2304	14.39
11:22 ET	3631	14.41
11:24 ET	3000	14.34
11:26 ET	1800	14.37
11:27 ET	4888	14.355
11:31 ET	6386	14.405
11:33 ET	2563	14.4
11:36 ET	3132	14.43
11:38 ET	2849	14.452
11:40 ET	300	14.44
11:42 ET	1413	14.46
11:44 ET	3611	14.48
11:45 ET	5600	14.48
11:47 ET	7006	14.53
11:49 ET	25484	14.46
11:51 ET	13182	14.46
11:54 ET	4260	14.48
11:56 ET	10702	14.52
11:58 ET	2100	14.49
12:00 ET	7249	14.46
12:03 ET	2215	14.46
12:05 ET	5645	14.42
12:07 ET	1296	14.435
12:09 ET	7790	14.44
12:12 ET	3485	14.42
12:14 ET	2770	14.34
12:16 ET	500	14.36
12:18 ET	1732	14.38
12:20 ET	900	14.4
12:21 ET	388	14.36
12:23 ET	2050	14.36
12:25 ET	9889	14.43
12:27 ET	6300	14.46
12:30 ET	7159	14.45
12:32 ET	300	14.45
12:34 ET	600	14.435
12:36 ET	3168	14.37
12:38 ET	1524	14.31
12:39 ET	4331	14.285
12:41 ET	2400	14.3
12:43 ET	2502	14.3
12:45 ET	12661	14.3
12:48 ET	1020	14.32
12:50 ET	700	14.35
12:52 ET	3668	14.36
12:54 ET	1348	14.34
12:56 ET	500	14.32
12:57 ET	4366	14.29
12:59 ET	6786	14.27
01:01 ET	1700	14.29
01:03 ET	3300	14.25
01:06 ET	300	14.23
01:08 ET	3151	14.2
01:12 ET	3633	14.24
01:14 ET	5023	14.24
01:15 ET	2501	14.2048
01:17 ET	1854	14.1526
01:19 ET	3603	14.17
01:21 ET	534	14.16
01:24 ET	1899	14.16
01:28 ET	100	14.17
01:30 ET	1860	14.2
01:32 ET	6044	14.24
01:33 ET	847	14.2
01:35 ET	11897	14.26
01:37 ET	300	14.24
01:39 ET	3500	14.26
01:42 ET	900	14.19
01:44 ET	500	14.21
01:46 ET	5544	14.24
01:48 ET	1193	14.23
01:50 ET	3701	14.26
01:51 ET	4336	14.31
01:53 ET	200	14.3075
01:55 ET	1852	14.29
02:00 ET	9033	14.3
02:02 ET	1300	14.28
02:04 ET	2240	14.25
02:06 ET	785	14.23
02:08 ET	4009	14.22
02:09 ET	700	14.22
02:11 ET	300	14.22
02:13 ET	790	14.23
02:15 ET	8149	14.23
02:18 ET	600	14.215
02:20 ET	200	14.21
02:22 ET	100	14.23
02:24 ET	500	14.2
02:26 ET	2823	14.24
02:27 ET	300	14.24
02:29 ET	1936	14.26
02:31 ET	20857	14.3
02:33 ET	6677	14.31
02:36 ET	4489	14.3
02:38 ET	1500	14.3
02:40 ET	1800	14.34
02:42 ET	400	14.35
02:44 ET	800	14.39
02:45 ET	8503	14.42
02:47 ET	600	14.41
02:49 ET	200	14.43
02:51 ET	1551	14.47
02:56 ET	3887	14.44
02:58 ET	606	14.46
03:00 ET	2400	14.445
03:02 ET	24200	14.38
03:03 ET	600	14.37
03:05 ET	3206	14.37
03:07 ET	300	14.38
03:09 ET	2400	14.43
03:12 ET	200	14.43
03:14 ET	1900	14.42
03:16 ET	29775	14.39
03:20 ET	4993	14.38
03:21 ET	18415	14.33
03:23 ET	2700	14.35
03:25 ET	700	14.41
03:27 ET	19811	14.37
03:30 ET	24353	14.43
03:32 ET	3000	14.45
03:34 ET	24480	14.39
03:36 ET	1399	14.38
03:38 ET	4396	14.395
03:39 ET	19024	14.43
03:41 ET	31073	14.38
03:43 ET	3896	14.38
03:45 ET	14460	14.32
03:48 ET	19508	14.25
03:50 ET	23381	14.265
03:52 ET	24938	14.27
03:54 ET	15767	14.22
03:56 ET	22510	14.15
03:57 ET	21708	14.17
03:59 ET	27430	14.24

Data delayed at least 15 minutes.

Jun 22, 2022
- CureVac Announces Voting Results of General Meeting, from 4:35PM ET on Wednesday Jun 22, 2022 by Accesswire
  4:35PM ET on Wednesday Jun 22, 2022 by Accesswire
Jun 9, 2022
- Sector Update: Health Care Stocks Lean Lower Premarket Thursday, from 9:15AM ET on Thursday Jun 09, 2022 by MT Newswires
  9:15AM ET on Thursday Jun 09, 2022 by MT Newswires
Jun 8, 2022
- CureVac Acquires Frame Cancer Therapeutics in Transaction Valued at 32 Million Euros, from 5:03PM ET on Wednesday Jun 08, 2022 by MT Newswires
  5:03PM ET on Wednesday Jun 08, 2022 by MT Newswires
- CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform, from 4:41PM ET on Wednesday Jun 08, 2022 by Accesswire
  4:41PM ET on Wednesday Jun 08, 2022 by Accesswire
- CureVac Announces Changes of CDO - Myriam Mendila to Succeed Klaus Edvardsen, from 4:25PM ET on Wednesday Jun 08, 2022 by Accesswire
  4:25PM ET on Wednesday Jun 08, 2022 by Accesswire

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCVAC CureVac NV	2.7B	0.0x	---
United StatesBEAM Beam Therapeutics Inc	2.8B	-11.0x	---
United StatesBPMC Blueprint Medicines Corp	3.0B	-4.5x	---
United StatesGMAB Genmab A/S	21.9B	66.3x	---
United StatesROIV Roivant Sciences Ltd	3.1B	-3.5x	---
United StatesINSM Insmed Inc	2.5B	-5.5x	---
As of 2022-07-05

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Contact Information

Headquarters: Friedrich-Miescher-Str. 15TUEBINGEN, Germany 72076
Phone: ---
Fax: ---

Executives

Independent Chairman of Supervisory Board: Baron Stephenne
Chief Executive Officer, Chief Operating Officer, Member of the Management Board: Franz-Werner Haas
Vice Chairman of the Supervisory Board: Friedrich von Bohlen und Halbach
Chief Financial Officer, Member of the Management Board: Pierre Kemula
Chief Operating Officer, Member of the Management Board: Malte Greune

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

Fundamentals Table
Market Cap	$2.7B
Revenue (TTM)	---
Shares Outstanding	187.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	---
Book Value	$3.83
P/E Ratio	0.0x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

CureVac NV
NASDAQ:CVACUnited States

Search Criteria

Charts

Recent News

Jun 22, 2022

CureVac Announces Voting Results of General Meeting, from 4:35PM ET on Wednesday Jun 22, 2022 by Accesswire

Jun 9, 2022

Sector Update: Health Care Stocks Lean Lower Premarket Thursday, from 9:15AM ET on Thursday Jun 09, 2022 by MT Newswires

Jun 8, 2022

CureVac Acquires Frame Cancer Therapeutics in Transaction Valued at 32 Million Euros, from 5:03PM ET on Wednesday Jun 08, 2022 by MT Newswires

CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform, from 4:41PM ET on Wednesday Jun 08, 2022 by Accesswire

CureVac Announces Changes of CDO - Myriam Mendila to Succeed Klaus Edvardsen, from 4:25PM ET on Wednesday Jun 08, 2022 by Accesswire

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar